TACTIVIN ACTION ON CYTOTOXICITY OF LYMPHOCYTES FROM PATIENTS WITH CHRONIC MYELOPROLIFERATIVE DISEASES

被引：0
|
作者：
GUSEVA, SA
机构：
来源：
GEMATOLOGIYA I TRANSFUZIOLOGIYA | 1994年 / 39卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The author studied natural cellular cytotoxicity (NCC) and antibody-dependent cytotoxicity (ADC) in lymphocytes from 31 patients with chronic myeloid leukemia (CML) and 37 patients with subleukemic myeloleukemia (SLM) in active clinical stage. The above parameters were found low in both diseases. Cytostatic therapy for CML did not affect NCC, but inhibited ADC. SLM treatment with myelobromol inhibited both cytotoxic responses. Combined therapy with adjuvant tactivin stimulated cytotoxic reactions activity. Tactivin positive effects persisted for two months.
引用
收藏
页码：22 / 25
页数：4
相关论文
共 50 条
  • [1] ANTIBODY DEPENDENT CYTOTOXICITY OF NEUTROPHILS AND MONOCYTES OF PERIPHERAL-BLOOD IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE DISEASES
    TISCHENKO, LM
    GUSEVA, SA
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1987, 32 (08): : 16 - 18
  • [2] HEMORRHAGIC COMPLICATIONS IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE DISEASES
    Simonovic, E.
    Macukanovic-Golubovic, L.
    Mladenovic, M.
    Colic, V.
    [J]. HAEMATOLOGICA, 2012, 97 : 642 - 643
  • [3] Expression of adhesion molecules by neurtrophils from patients with chronic myeloproliferative diseases
    Caruccio, L.
    [J]. TRANSFUSION, 2007, 47 (03) : 137A - 137A
  • [4] Anagrelide treatment in 52 patients with chronic myeloproliferative diseases
    Penninga, E
    Jensen, BA
    Hansen, PB
    Clausen, NT
    Mourits-Andersen, T
    Nielsen, OJ
    Hasselbalch, HC
    [J]. CLINICAL AND LABORATORY HAEMATOLOGY, 2004, 26 (05): : 335 - 340
  • [5] NONSPECIFIC DEFENSE FACTORS IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE DISEASES
    SHARDAKOV, VI
    KOPANEVA, TG
    SHULYATIEVA, TN
    KUZNETSOVA, NN
    NIKIFOROVA, TV
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1990, 35 (06): : 22 - 24
  • [6] IMMUNOMODULATING AGENTS THYMALIN AND TACTIVIN IN THERAPY OF CHRONIC DISEASES OF THE LIVER
    YAKHONTOVA, OI
    DUDANOVA, OP
    KHAVINSON, VK
    [J]. SOVETSKAYA MEDITSINA, 1990, (06): : 85 - 88
  • [7] CHRONIC HEPATIC DISEASES - SECONDARY THYMIC INSUFFICIENCY AND IMMUNOCORRECTION WITH TACTIVIN
    SARKISYAN, SV
    [J]. KLINICHESKAYA MEDITSINA, 1994, 72 (06): : 45 - 48
  • [8] Chronic myeloproliferative diseases (CMPE)
    Rechberger, Ernst
    Webersinke, Gerald
    Petzer, Andreas L.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 59 - 76
  • [9] HISTOPATHOLOGY OF CHRONIC MYELOPROLIFERATIVE DISEASES
    GEORGII, A
    CHORITZ, H
    BUSCHE, G
    KREFT, A
    BUHR, T
    [J]. PATHOLOGE, 1995, 16 (01): : 62 - 69
  • [10] Chronic myeloproliferative diseases and pregnancy
    Tsvetaeva, N. V.
    Khoroshko, N. D.
    Sokolova, M. A.
    Shmakov, R. V.
    Semenova, E. A.
    Lopukhin, V. O.
    Romanova, E. A.
    Sudarikov, A. B.
    Vasilyev, S. A.
    Orel, E. B.
    Rudakova, V. E.
    Ivanova, V. L.
    Serebryanaya, L. A.
    T Sedova, G.
    Manakova, T. E.
    Tutaeva, V. V.
    Levina, A. A.
    Mamukova, Yu. I.
    [J]. TERAPEVTICHESKII ARKHIV, 2006, 78 (10): : 68 - 72
12345